Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

HellenJune Mar. 13 at 12:52 PM

$IQV the middleman not needed in R&D. Labourious unwanted processes that inflate the price of medicines and delay the access to the market. The parasit of the Healtchare industry. They work could be completly replaced by AI at no cost

1 · Reply

HellenJune Mar. 13 at 12:47 PM

$IQV When FDA wil update the R&D guidelines CROs will become invizible or obsolete. AI will replace their work entirely at no cost

0 · Reply

TheClockworkGroup Mar. 10 at 11:04 PM

$IQV #NYSE | The markets are unpredictable, but with #WaveE, one of our cutting-edge #AI-driven #algorithmic #breakout #daytrading strategies, you too can make calculated trades like a pro! Scalped profits of +$1,977.56 trading #IQVIAHoldingsInc., $IQV shares today! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader, @TradeStation & @TradingView...

0 · Reply

RunnerSignals Mar. 10 at 8:38 PM

Top stock upgrades today in the BUZZ $APLS $ASML $CAVA $IQV $PLUG steady gains post-rating changes, correlation to sector news, late buyers pushed close higher https://stocksrunner.com/news/2026-03-10-top-stock-upgrades-today-in-the-buzz

0 · Reply

erevnon Mar. 9 at 7:31 PM

TD Cowen upgrades IQVIA Holdings $IQV from Hold to Buy and raises the price target from $174 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

IN0V8 Mar. 9 at 3:43 PM

$IQV Opportunity Barclays raises to overweight from equal-weight TD Cowen raises target price to $213 from $174 TD Cowen raises to buy from hold

0 · Reply

TheClockworkGroup Feb. 27 at 10:53 PM

$IQV #NYSE | The markets are unpredictable, but with #WaveE, one of our cutting-edge #AI-driven #algorithmic #breakout #daytrading strategies, you too can make calculated trades like a pro! Scalped profits of +$5,422.06 trading #IQVIAHoldingsInc., $IQV shares today! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader, @TradeStation & @TradingView...

0 · Reply

LandonCapital Feb. 25 at 5:30 PM

$IQV https://landoncapital.net/iqvia-nyse-iqv-to-acquire-drug-discovery-assets/

0 · Reply

d_risk Feb. 17 at 4:38 PM

$IQV $HLMN - Hillman Solutions Corp - 10K - Updated Risk Factors HLMN’s 2026 10-K risk revamp spotlights heavy reliance on two big-box customers post-True Value bankruptcy, deeper tariffs/China-Taiwan and international trade exposure, new ERP and cyber/IT vulnerabilities, tighter focus on inventory and working capital, more granular leverage and liquidity constraints amid volatile capital markets, and expanded IP and FX risks, while trimming M&A, legal proceedings, and seasonal/weather risk detail. #IndustrialHardware #CustomerConcentrationRisk #TradeTariffs #CybersecurityVulnerabilities #FinancialLiquidity 🟢 Added 🟠 Removed https://d-risk.ai/HLMN/10-K/2026-02-17

0 · Reply

d_risk Feb. 17 at 3:57 PM

$IQV - IQVIA Holdings Inc - 10K - Updated Risk Factors IQVIA’s 10-K risk section is now longer, more detailed, and more tech- and regulation-focused: it trims multiple execution, M&A, client concentration, tax, and capital markets risks while expanding disclosures on AI, data and third‑party dependencies, cyber/IT systems, IP protection, international operations, sustainability, restructuring, leverage covenants, and shareholder rights. #HealthcareTechnology #AIIntegration #CybersecurityRisks #RegulatoryCompliance #InternationalOperations 🟢 Added 🟠 Removed https://d-risk.ai/IQV/10-K/2026-02-17

0 · Reply

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

Mar 12, 2026, 2:12 PM EDT - 9 days ago

IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 9, 2026, 12:27 PM EDT - 12 days ago

IQVIA Holdings Inc. (IQV) Presents at Leerink Global Healthcare Conference 2026 Transcript

Mar 2, 2026, 4:30 PM EST - 19 days ago

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 4:15 PM EST - 19 days ago

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

Feb 28, 2026, 5:50 AM EST - 21 days ago

IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder

Feb 27, 2026, 4:47 PM EST - 22 days ago

IQVIA Releases its 2025 Sustainability Report

Feb 26, 2026, 3:07 PM EST - 23 days ago

IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript

Feb 25, 2026, 7:00 AM EST - 24 days ago

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Feb 24, 2026, 9:01 AM EST - 25 days ago

10 stocks Wall Street expects to roar back after dropping at least 20% in 2026

APP BKNG COF CSGP KKR NOW ORCL

Feb 18, 2026, 4:15 PM EST - 4 weeks ago

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

Feb 12, 2026, 5:07 AM EST - 5 weeks ago

Oakmark Global All Cap Strategy Q4 2025 Performance Review

BABA CNH

Feb 10, 2026, 8:00 AM EST - 5 weeks ago

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

Feb 5, 2026, 3:24 PM EST - 6 weeks ago

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript

Feb 5, 2026, 9:07 AM EST - 6 weeks ago

IQVIA forecasts weak annual profit on higher interest expenses

Feb 5, 2026, 7:00 AM EST - 6 weeks ago

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Jan 29, 2026, 8:00 AM EST - 7 weeks ago

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

Jan 22, 2026, 4:05 PM EST - 2 months ago

IQVIA Named to the Fortune® World's Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

Jan 20, 2026, 4:45 PM EST - 2 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

Dec 11, 2025, 1:56 PM EST - 3 months ago

IQVIA: Increasingly Indispensable In Drug Development

Dec 2, 2025, 8:00 AM EST - 3 months ago

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Nov 12, 2025, 5:43 AM EST - 4 months ago

Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors

BABA CHTR CNC CNH GOOG GOOGL

Nov 11, 2025, 2:31 PM EST - 4 months ago

IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 7, 2025, 2:15 AM EST - 4 months ago

Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation

CRM GOOG GOOGL KDP MOH WBD

Nov 5, 2025, 4:15 PM EST - 4 months ago

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

Oct 28, 2025, 1:52 PM EDT - 5 months ago

IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 7:53 AM EDT - 5 months ago

IQVIA narrows annual profit forecast amid continued research contract cancellations

Oct 28, 2025, 7:00 AM EDT - 5 months ago

IQVIA Reports Third-Quarter 2025 Results

Oct 24, 2025, 4:30 AM EDT - 5 months ago

Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning

APD CNC COF FISV IVZ JNJ LRCX

Oct 21, 2025, 4:15 PM EDT - 5 months ago

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

Sep 30, 2025, 4:15 PM EDT - 6 months ago

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

Sep 26, 2025, 9:40 AM EDT - 6 months ago

ILMN Stock vs. IQV Stock

ILMN

Sep 16, 2025, 8:00 AM EDT - 6 months ago

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Sep 11, 2025, 2:00 AM EDT - 6 months ago

IQVIA: A Positive Long-Term Outlook Despite Trump Legislation

Sep 10, 2025, 8:00 AM EDT - 6 months ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Sep 2, 2025, 9:41 AM EDT - 7 months ago

IQVIA names Michael Fedock as financial chief

Sep 2, 2025, 9:00 AM EDT - 7 months ago

IQVIA Announces CFO Transition in Early 2026

Aug 28, 2025, 8:00 AM EDT - 7 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 7 months ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

Aug 18, 2025, 9:00 AM EDT - 7 months ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

Jul 22, 2025, 5:40 PM EDT - 8 months ago

IQVIA: Q2 Earnings Exceeded My Expectations

Jul 22, 2025, 2:00 PM EDT - 8 months ago

IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 8:42 AM EDT - 8 months ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 7:00 AM EDT - 8 months ago

IQVIA Reports Second-Quarter 2025 Results

Jul 16, 2025, 7:54 AM EDT - 8 months ago

IQVIA: Competition Is Creating More Challenges Over The Long Haul

Jul 1, 2025, 7:00 AM EDT - 9 months ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jun 16, 2025, 9:00 AM EDT - 9 months ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 11, 2025, 7:00 AM EDT - 10 months ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

Jun 10, 2025, 2:23 PM EDT - 10 months ago

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

Jun 2, 2025, 4:37 PM EDT - 10 months ago

IQVIA Announces Pricing of Senior Notes

HellenJune Mar. 13 at 12:52 PM

1 · Reply

HellenJune Mar. 13 at 12:47 PM

$IQV When FDA wil update the R&D guidelines CROs will become invizible or obsolete. AI will replace their work entirely at no cost

0 · Reply

TheClockworkGroup Mar. 10 at 11:04 PM

0 · Reply

RunnerSignals Mar. 10 at 8:38 PM

0 · Reply

erevnon Mar. 9 at 7:31 PM

TD Cowen upgrades IQVIA Holdings $IQV from Hold to Buy and raises the price target from $174 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

IN0V8 Mar. 9 at 3:43 PM

$IQV Opportunity Barclays raises to overweight from equal-weight TD Cowen raises target price to $213 from $174 TD Cowen raises to buy from hold

0 · Reply

TheClockworkGroup Feb. 27 at 10:53 PM

$IQV #NYSE | The markets are unpredictable, but with #WaveE, one of our cutting-edge #AI-driven #algorithmic #breakout #daytrading strategies, you too can make calculated trades like a pro! Scalped profits of +$5,422.06 trading #IQVIAHoldingsInc., $IQV shares today! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader, @TradeStation & @TradingView...

0 · Reply

LandonCapital Feb. 25 at 5:30 PM

$IQV https://landoncapital.net/iqvia-nyse-iqv-to-acquire-drug-discovery-assets/

0 · Reply

d_risk Feb. 17 at 4:38 PM

0 · Reply

d_risk Feb. 17 at 3:57 PM

0 · Reply

Estimize Feb. 9 at 3:06 PM

Wall St is expecting 2.84 EPS for $IQV Q1 [Reporting 04/23 BMO] http://www.estimize.com/intro/iqv?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Feb. 5 at 5:52 PM

$IQV just delivered a clean Q4 beat — and guidance is turning heads 👀 Q4 2025 earnings and revenues topped estimates with double-digit Y/Y sales growth, driven by strong segment gains, alongside upbeat 2026 revenue guidance. See what this could mean next 👉 https://www.zacks.com/stock/news/2830156/iqvia-q4-earnings-revenues-beat-estimates-increase-yy?cid=sm-stocktwits-2-2830156-teaser-32194&ADID=SYND_STOCKTWITS_TWEET_2_2830156_TEASER_32194

0 · Reply

ZacksResearch Feb. 5 at 4:52 PM

$IQV crushes Q4 earnings & revenue estimates! 📈 💰 Adjusted EPS jumped 9.6% YoY to $3.42, outpacing the Zacks Consensus Estimate. 📊 Total revenues rose 10.3% YoY to $4.4B, beating estimates by 2.8%. 🚀 Strong segmental growth drives performance, with R&D and Tech segments meeting expectations while Contract Sales and Medical Solutions surpassed them. Discover what's fueling IQVIA's momentum 👉 https://www.zacks.com/stock/news/2830156/iqvia-q4-earnings-revenues-beat-estimates-increase-yy?cid=sm-stocktwits-2-2830156-body-32157&ADID=SYND_STOCKTWITS_TWEET_2_2830156_BODY_32157

1 · Reply

1986iamwallstreet Feb. 5 at 2:38 PM

$IQV flush city 🩸🩸🩸🩸🩸🩸

0 · Reply

StocktwitsEarnings Feb. 5 at 12:11 PM

$IQV Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $3.02 up 23.77% YoY • Reported revenue of $4.36B up 10.26% YoY • For full-year 2026, IQVIA expects revenue between $17.15B to $17.35B, Adjusted EBITDA from $3.98B to $4.03B, and Adjusted Diluted Earnings per Share of $12.55 to $12.85.

0 · Reply

1986iamwallstreet Feb. 5 at 12:09 PM

$IQV IQVIA Hldgs Sees FY2026 Adj EPS $12.55-$12.85 vs $12.95 Est; Sees Sales $17.150B-$17.350B vs $17.071B Est 🩸🩸🩸🩸🩸🩸🩸

0 · Reply

AlgorithmAdvisors Feb. 4 at 11:30 AM

$IQV is a leading CRO facing biotech funding headwinds; backlog conversion and large pharma demand provide stability.

0 · Reply

ZacksResearch Feb. 3 at 5:13 PM

Earnings setup for $IQV — growth expectations are heating up 📈 IQV is set to report fourth-quarter 2025 earnings on Feb. 5, with revenues expected to rally 7.2% year over year to $4.2B and EPS expected to rise 9% on segment growth. Full earnings preview and key details here 👉 https://www.zacks.com/stock/news/2828079/iqvia-set-to-report-q4-earnings-heres-what-you-should-know?cid=sm-stocktwits-2-2828079-teaser-31718&ADID=SYND_STOCKTWITS_TWEET_2_2828079_TEASER_31718

0 · Reply

ZacksResearch Feb. 3 at 4:13 PM

$IQV set to report Q4 earnings — will it continue its growth trend? 📊 IQVIA has surpassed the Zacks Consensus Estimate in the last four quarters, averaging a 1.6% surprise. For Q4, revenue is expected to grow 7.2% YoY, with EPS estimated at $3.4, a 9% increase. Discover the full earnings preview here 👉 https://www.zacks.com/stock/news/2828079/iqvia-set-to-report-q4-earnings-heres-what-you-should-know?cid=sm-stocktwits-2-2828079-body-31719&ADID=SYND_STOCKTWITS_TWEET_2_2828079_BODY_31719

0 · Reply

OfficialStocktwitsUser Jan. 27 at 5:51 PM

$IQV RSI: 52.50, MACD: 3.5067 Vol: 6.23, MA20: 237.23, MA50: 229.22 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

AcceleratorModel Jan. 23 at 6:10 AM

$IQV may be time to come back for more

0 · Reply

Market Cap	28.18B
Revenue (ttm)	16.31B
Net Income (ttm)	1.36B
EPS (ttm)	N/A
PE Ratio	15.31
Forward PE	14.44
Profit Margin	8.34%
Debt to Equity Ratio	2.37

Volume	3,462,100
Avg Vol	2,247,430
Day's Range	N/A - N/A
Shares Out	169.70M
Stochastic %K	21%
Beta	1.39
Analysts	Strong Sell
Price Target	$233.67